Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.470
-0.370 (-13.03%)
At close: Feb 5, 2026, 4:00 PM EST
2.410
-0.060 (-2.43%)
After-hours: Feb 5, 2026, 4:22 PM EST
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $25.89 million as of February 5, 2026. Its market cap has decreased by -42.70% in one year.
Market Cap
25.89M
Enterprise Value
25.40M
1-Year Change
-42.70%
Ranking
Category
Stock Price
$2.47
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $25.89M, a decrease of -79.31%. That is a compound annual growth rate of -57.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 30.63M | 50.15% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 30.76M |
| NeuroSense Therapeutics | 30.46M |
| Barinthus Biotherapeutics | 30.42M |
| Cue Biopharma | 30.11M |
| Lixte Biotechnology Holdings | 29.62M |
| Palatin Technologies | 29.61M |
| AN2 Therapeutics | 29.59M |
| Liminatus Pharma | 28.96M |